CLDN1 and pancreatic neoplasm: CLDN1 promotes the growth and progression of various tumors, including breast cancer, melanoma, oral squamous cell carcinoma, thyroid cancer, ovarian cancer, colon cancer, gastric cancer, hepatocellular carcinoma, and pancreatic cancer.